The United States and China, as global leaders in artificial intelligence and biotechnology, hold unique responsibility to curb the misuse of these technologies in bioterrorism. Experts stress that cooperation between both nations is crucial to managing risks that neither can address alone.
Recent discussions between US and Chinese biosecurity experts have advanced the idea of stronger safeguards, particularly the adoption of mandatory DNA synthesis screening. This process checks genetic material orders to prevent the accidental or intentional creation of dangerous pathogens. Despite controlling most of the world’s DNA synthesis market, neither country currently enforces such screening, leaving a mutual vulnerability.
Mandatory screening would directly support the shared goal of preventing terrorists from obtaining genetic components needed to engineer biological weapons. Common standards would also promote responsibility in the broader global biotechnology market, encouraging companies to adopt safer practices.
In the US, bipartisan legislation recently introduced by Senators Tom Cotton and Amy Klobuchar aims to strengthen oversight of gene synthesis providers by requiring both order and customer screening. This creates a timely opportunity for China to align its regulations with these efforts, fostering international collaboration.
Beyond DNA synthesis, the integration of AI into biology introduces further security concerns. AI models at early research stages could be exploited to design or modify biological agents. Experts argue that evaluating AI tools for potential misuse risks is essential before genetic material synthesis even begins, marking a critical step in comprehensive biosecurity governance.
Despite geopolitical tensions, these shared biosecurity challenges present a common ground for cooperation. Addressing AI-driven biological threats together could reduce global vulnerabilities and accelerate innovation with confidence, reinforcing both countries’ leadership in biotechnology and national security.